Lopes-Virella MF - Search Results

1

Immunoassay of modified forms of human low density lipoprotein in isolated circulating immune complexes.

Virella G, Colglazier J, Chassereau C, Hunt KJ, Baker NL, Lopes-Virella MF. Virella G, et al. J Immunoassay Immunochem. 2013;34(1):61-74. doi: 10.1080/15321819.2012.683500. J Immunoassay Immunochem. 2013. PMID: 23323982

2

Immune complexes containing malondialdehyde (MDA) LDL induce apoptosis in human macrophages.

Virella G, Wilson K, Elkes J, Hammad SM, Rajab HA, Li Y, Chassereau C, Huang Y, Lopes-Virella M. Virella G, et al. Clin Immunol. 2018 Feb;187:1-9. doi: 10.1016/j.clim.2017.06.010. Epub 2017 Jul 8. Clin Immunol. 2018. PMID: 28689783

3

Lipoprotein autoantibodies: measurement and significance.

Virella G, Lopes-Virella MF. Virella G, et al. Clin Diagn Lab Immunol. 2003 Jul;10(4):499-505. doi: 10.1128/cdli.10.4.499-505.2003. Clin Diagn Lab Immunol. 2003. PMID: 12853376 Free PMC article. Review. No abstract available.

4

Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies.

Virella G, Thorpe SR, Alderson NL, Derrick MB, Chassereau C, Rhett JM, Lopes-Virella MF. Virella G, et al. J Lipid Res. 2004 Oct;45(10):1859-67. doi: 10.1194/jlr.M400095-JLR200. Epub 2004 Jul 16. J Lipid Res. 2004. PMID: 15258197 Free article.

5

Development of capture assays for different modifications of human low-density lipoprotein.

Virella G, Derrick MB, Pate V, Chassereau C, Thorpe SR, Lopes-Virella MF. Virella G, et al. Clin Diagn Lab Immunol. 2005 Jan;12(1):68-75. doi: 10.1128/CDLI.12.1.68-75.2005. Clin Diagn Lab Immunol. 2005. PMID: 15642987 Free PMC article.

6

The immunogenicity of modified lipoproteins.

Lopes-Virella MF, Thorpe SR, Derrick MB, Chassereau C, Virella G. Lopes-Virella MF, et al. Ann N Y Acad Sci. 2005 Jun;1043:367-78. doi: 10.1196/annals.1333.043. Ann N Y Acad Sci. 2005. PMID: 16037258 Review.

7

OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages.

Saad AF, Virella G, Chassereau C, Boackle RJ, Lopes-Virella MF. Saad AF, et al. J Lipid Res. 2006 Sep;47(9):1975-83. doi: 10.1194/jlr.M600064-JLR200. Epub 2006 Jun 27. J Lipid Res. 2006. PMID: 16804192 Free article.

8

Atherogenesis and the humoral immune response to modified lipoproteins.

Virella G, Lopes-Virella MF. Virella G, et al. Atherosclerosis. 2008 Oct;200(2):239-46. doi: 10.1016/j.atherosclerosis.2008.03.025. Epub 2008 Apr 12. Atherosclerosis. 2008. PMID: 18513726 Free PMC article. Review.

9

Clinical significance of the humoral immune response to modified LDL.

Lopes-Virella MF, Virella G. Lopes-Virella MF, et al. Clin Immunol. 2010 Jan;134(1):55-65. doi: 10.1016/j.clim.2009.04.001. Epub 2009 May 8. Clin Immunol. 2010. PMID: 19427818 Free PMC article. Review.

10

LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses.

Klein RL, Carter RE, Jenkins AJ, Lyons TJ, Baker NL, Gilbert GE, Virella G, Lopes-Virella MF; DCCT/EDIC Research Group. Klein RL, et al. J Diabetes Complications. 2011 Mar-Apr;25(2):73-82. doi: 10.1016/j.jdiacomp.2010.03.001. Epub 2010 Jun 3. J Diabetes Complications. 2011. PMID: 20605479 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters